Literature DB >> 30429255

It Is Not about the Assay: Preanalytical Screening Is the Key to Reducing Clostridioides difficile Infection.

Siu-Kei Chow1, Azita Naderpour2, Julianna Van Enk3.   

Abstract

Entities:  

Keywords:  Clostridium difficilezzm321990; antibiotic stewardship; hospital infections; infection control

Year:  2019        PMID： 30429255      PMCID： PMC6355535          DOI： 10.1128/JCM.01553-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  7 in total

1.  National Healthcare Safety Network laboratory-identified Clostridium difficile event reporting: A need for diagnostic stewardship.

Authors:  Clare Rock; Zoi Pana; Surbhi Leekha; Polly Trexler; Jennifer Andonian; Avinash Gadala; Karen C Carroll; Lisa L Maragakis
Journal:  Am J Infect Control       Date:  2018-01-02       Impact factor: 2.918

2.  Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

Authors:  Ferric C Fang; Christopher R Polage; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

3.  Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.

Authors:  Erik R Dubberke; Zhuolin Han; Linda Bobo; Tiffany Hink; Brenda Lawrence; Susan Copper; Joan Hoppe-Bauer; Carey-Ann D Burnham; William Michael Dunne
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

4.  Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.

Authors:  Cynthia Y Truong; Saurabh Gombar; Richard Wilson; Gopalakrishnan Sundararajan; Natasa Tekic; Marisa Holubar; John Shepard; Alexandra Madison; Lucy Tompkins; Neil Shah; Stan Deresinski; Lee F Schroeder; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-03-01       Impact factor: 5.948

5.  Burden of Clostridium difficile infection in the United States.

Authors:  Fernanda C Lessa; Yi Mu; Wendy M Bamberg; Zintars G Beldavs; Ghinwa K Dumyati; John R Dunn; Monica M Farley; Stacy M Holzbauer; James I Meek; Erin C Phipps; Lucy E Wilson; Lisa G Winston; Jessica A Cohen; Brandi M Limbago; Scott K Fridkin; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

6.  Reducing Clostridium difficile Colitis Rates Via Cost-Saving Diagnostic Stewardship.

Authors:  Christina Yen; Paul Holtom; Susan M Butler-Wu; Noah Wald-Dickler; Ira Shulman; Brad Spellberg
Journal:  Infect Control Hosp Epidemiol       Date:  2018-04-03       Impact factor: 3.254

7.  Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.

Authors:  Katherine Schultz; Emily Sickbert-Bennett; Ashley Marx; David J Weber; Lauren M DiBiase; Stacy Campbell-Bright; Lauren E Bode; Mike Baker; Tom Belhorn; Mark Buchanan; Sherie Goldbach; Jacci Harden; Emily Hoke; Beth Huenniger; Jonathan J Juliano; Michael Langston; Heather Ritchie; William A Rutala; Jason Smith; Shelley Summerlin-Long; Lisa Teal; Peter Gilligan
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948
  7 in total
  6 in total

1.  Guidelines Support the Value of Stand-Alone Nucleic Acid Amplification Tests for Clostridioides (Clostridium) difficile Infection.

Authors:  Fred C Tenover; David H Persing; Ferric Fang
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

2.  Reply to Tenover et al., "Guidelines Support the Value of Stand-Alone Nucleic Acid Amplification Tests for Clostridioides (Clostridium) difficile Infection".

Authors:  Johanna Sandlund; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

3.  Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.

Authors:  Johanna Sandlund; Joel Estis; Phoebe Katzenbach; Niamh Nolan; Kirstie Hinson; Jennifer Herres; Troy Pero; Gwyn Peterson; Jeung-Mi Schumaker; Craig Stevig; Rhonda Warren; Tsubasa West; Siu-Kei Chow
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

Review 4.  Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.

Authors:  Johanna Sandlund; Kerrie Davies; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

5.  Evaluation of the Cepheid Xpert C. difficile diagnostic assay: an update meta-analysis.

Authors:  Yuanyuan Bai; Yingying Hao; Zhen Song; Wenjun Chu; Yan Jin; Yueling Wang
Journal:  Braz J Microbiol       Date:  2021-08-29       Impact factor: 2.476

6.  Rethinking the "Pan-Culture": Clinical Impact of Respiratory Culturing in Patients With Low Pretest Probability of Ventilator-Associated Pneumonia.

Authors:  Owen R Albin; Louis Saravolatz; Joshua Petrie; Oryan Henig; Keith S Kaye
Journal:  Open Forum Infect Dis       Date:  2022-04-14       Impact factor: 4.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.